Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Cited by (1,000)

Items 301–400 of 1,000

1. Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
   Stefan Hans Hohnloser, Philippe Gabríel Steg, Jonas Oldgren, Georg Nickenig, Róbert Gábor Kiss, Zeki Öngen, Jose Luis Navarro Estrada, Ton Oude Ophuis, Gregory Y.H. Lip, Matias Nordaby et al. · 2019 · JACC: Cardiovascular Interventions
2. Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials
   Mattía Galli, Felicita Andreotti, Domenico D’Amario, Italo Porto, Filippo Crea · 2020 · Journal of the American College of Cardiology
3. Diretriz de Síndrome Coronariana Crônica – 2025
   Luı́z Antonio Machado César, Luís Henrique Wolff Gowdak, Ricardo Pavanello, João Fernando Monteiro Ferreira, Bruno Mahler Mioto, Nilson Tavares Poppi, Cledson Jatiniel Lima Mendonça, Adenalva Lima de Souza Beck, Adriana Soares Xavier de Brito, Alexandre Abizaid et al. · 2025 · Arquivos Brasileiros de Cardiologia
4. Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke
   Maria Cecilia Bahit, Amit N. Vora, Zhuokai Li, DANIEL M. WOJDYLA, Laine Elliott Thomas, Shaun G. Goodman, RONALD S. ARONSON, Joseph Dedrick Jordan, Brad J. Kolls, Keith E. Dombrowski et al. · 2022 · JAMA Cardiology
5. 2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization
   GREGORY J. DEHMER, Cindy Lee Grines, Faisal G. Bakaeen, Dorian L. Beasley, Theresa M. Beckie, Jack H. Boyd, Joaquin E. Cigarroa, Sandeep R. Das, Rebecca L. Diekemper, Jennifer Frampton et al. · 2023 · Journal of the American College of Cardiology
6. 2024 Korean Society of Myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency Guideline for the Pharmacotherapy of Acute Coronary Syndromes
   Hyun Kuk Kim, Seungeun Ryoo, Seung Hun Lee, Doyeon Hwang, Ki Hong Choi, Jungeun Park, Hyeon‐Jeong Lee, Chang‐Hwan Yoon, Jang Hoon Lee, Joo‐Yong Hahn et al. · 2024 · Korean Circulation Journal
7. Associations Between Albumin/Neutrophil-to-Lymphocyte Ratio Score and New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction Undergoing PCI
   Shaobing Yang, Hong-Wei Zhao · 2025 · Journal of Inflammation Research
8. Advances in Clinical Cardiology 2019: A Summary of Key Clinical Trials
   Katie Linden, Jonathan A. Mailey, Aileen Kearney, Ian B A Menown · 2020 · Advances in Therapy
9. Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation
   Young Choi, Yunhee Lee, Sung‐Hwan Kim, Sunhwa Kim, Ju Youn Kim, Tae‐Seok Kim, Youmi Hwang, Jihoon Kim, Sung-Won Jang, Man Young Lee et al. · 2021 · Heart
10. Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics
    Siena Meador, Shannon Dyke, John C. Togami, Brianna Kuskov, Allison Burnett · 2021 · Journal of Thrombosis and Thrombolysis
11. Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome
    Antonio Greco, Davide Capodanno · 2022 · European Heart Journal Supplements
12. Dual-Antithrombotic Therapy With DOACs After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials
    Mohammed Shurrab, Asaf Danon, Sami M. Alnasser, Benedict M. Glover, Anna Kaoutskaia, Mark A. Henderson, David M. Newman, Eugene Crystal, Dennis T. Ko · 2019 · Canadian Journal of Cardiology
13. Atrial fibrillation: an update on management
    C. McCallum, Deep Chandh Raja, Rajeev Kumar Pathak · 2019 · Australian Prescriber
14. A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)
    Farhad Pazan, Rónán Collins, Victor Machado Gil, Olivier Hanon, Roland Hardt, Martin Hoffmeister, Pedro F. Monteiro, Terence J. Quinn, Dieter Ropers, Giuseppe Sergi et al. · 2020 · Drugs & Aging
15. Anticoagulation for atrial fibrillation after cardiac surgery: Do guidelines reflect the evidence?
    Subhasis Chatterjee, Niv Ad, Vinay Badhwar, Alan Marc Gillinov, John Hunter Alexander, Marc Richard Moon · 2023 · Journal of Thoracic and Cardiovascular Surgery
16. Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial
    Ashley Verburg, Willem L. Bor, I. Tarik Küçük, Josè P.S. Henriques, Maarten A. Vink, Willem-Peter T. Ruifrok, Jacobus Plomp, Ton A.C.M. Heestermans, Carl E. Schotborgh, Pieter J. J. Vlaar et al. · 2024 · EuroIntervention
17. The SAFEST Study: Survey on Antiplatelets in Flow Diversion for Aneurysm Endovascular Treatment
    Sophia Hohenstatt, Dominik F. Vollherbst, Thanh Ngoc Nguyen, Zhongrong Miao, Mai Duy Ton, Hiroshi Yamagami, Adam Andrew Dmytriw, Gabriele Maliandi, Martin Bendszus, Jessica Jesser et al. · 2024 · Stroke Vascular and Interventional Neurology
18. Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS)
    Gregory Y.H. Lip, Robert Benamouzig, Anne‐Céline Martin, Giancarlo Pesce, Gaëlle Gusto, Nadia Quignot, Artak Khachatryan, Feng Dai, Fouad Sedjelmaci, José Chaves et al. · 2025 · PLoS ONE
19. Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation
    Manasi Tannu, Renato D. Lópes, DANIEL M. WOJDYLA, Shaun G. Goodman, Ronald Aronson, Roxana Mehran, Christopher Bull Granger, Stephan Windecker, John Hunter Alexander, W. Schuyler Jones · 2025 · Journal of the American College of Cardiology
20. Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
    Ludwig Traby, Marietta Kollars, Alexandra Kaider, Jolanta Maria Siller-Matula, Martin F. Wolkersdorfer, Michael Wolzt, Paul Alexander Kyrle, Sabine Eichinger · 2019 · Clinical Pharmacology & Therapeutics
21. Dual antithrombotic therapy for atrial fibrillation and PCI
    Davide Capodanno, Dominick Joseph Angiolillo · 2019 · The Lancet
22. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy
    Aaron Desai, César E. Escamilla-Ocañas, Deepika Dilip, Hamidreza Saber, Rahul H. Damani · 2021 · Journal of Stroke and Cerebrovascular Diseases
23. Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Soonil Kwon, Jin‐Hyung Jung, Eue‐Keun Choi, Seung‐Woo Lee, Jiesuck Park, So‐Ryoung Lee, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh et al. · 2021 · Korean Circulation Journal
24. Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis.
    Grigorios Tsigkas, Anastasiοs Apostolos, Stefanos Despotopoulos, Georgios Vasilagkos, Angeliki Papageorgiou, Eleftherios M. Kallergis, Georgios Leventopoulos, Virginia Mplani, Ioanna C. Koniari, Dimitrios Velissaris et al. · 2021 · PubMed Central
25. Edoxaban in cardiovascular disease management: Review
    Sharanyah Srinivasan, Muhammad Ajmal, Cristina Pecci, Tom A. Lassar · 2021 · British Journal of Clinical Pharmacology
26. Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation—What Has Changed and How Does This Affect Daily Practice
    Johanna Tonko, Matthew James Wright · 2021 · Journal of Clinical Medicine
27. Identification of linoleic acid as an antithrombotic component of Wenxin Keli via selective inhibition of p-selectin-mediated platelet activation
    Qianqian Tao, Guangxu Xiao, Taiyi Wang, Lei Zhang, Mingxing Yu, Li Jen Peng, Linhong Han, Xiaoli Du, Wenrun Han, Shuang He et al. · 2022 · Biomedicine & Pharmacotherapy
28. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis
    Shuyi Wu, Meina Lv, Jiana Chen, Shaojun Jiang, Mingrong Chen, Zongwei Fang, Zhiwei Zeng, Jiafen Qian, Wenlin Xu, Chengfu Guan et al. · 2022 · Supportive Care in Cancer
29. Impact of Direct Oral Anticoagulant Off-Label Reduced Dose in Combination With Antiplatelet Agents on Clinical Outcome ― Propensity Score-Matching Analysis From the DIRECT Real-World Non-Valvular Atrial Fibrillation Registry ―
    Tomoaki Kobayashi, Yohei Sotomi, Akio Hirata, Yasushi Sakata, Atsushi Hirayama, Yoshiharu Higuchi · 2020 · Circulation Reports
30. Direct oral anticoagulants to treat left ventricular thrombus—A systematic review and meta‐analysis: ELECTRAM investigators
    Siddharth Shah, Kuldeep Bharat Shah, Mohit K. Turagam, Abhinav Sharma, Andrea Natale, Dhanunjaya Lakkireddy, Jalaj Garg · 2021 · Journal of Cardiovascular Electrophysiology
31. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
    Matthew William Sherwood, Aakriti Gupta, Sreekanth Vemulapalli, Zhuokai Li, Jonathan Paul Piccini, John Kevin Harrison, David Dai, Amit N. Vora, Michael J. Mack, David R. Holmes et al. · 2021 · Circulation Cardiovascular Interventions
32. Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation
    Brian A. Bergmark, Thomas A. Zelniker, Miae Kim, Mandeep R. Mehra, Garrick C. Stewart, Deborah S. Page, Erica L. Woodcome, Michael M. Givertz · 2021 · Clinical Transplantation
33. Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome
    Christoph Clemens Kaufmann, Marie Muthspiel, Laura Lunzer, Edita Pogran, David Zweiker, Achim Leo Burger, Johann Wojta, Kurt Huber · 2024 · Journal of Clinical Medicine
34. Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention
    Lina Manzi, Domenico Florimonte, Imma Forzano, Federica Buongiorno, Luca Sperandeo, Domenico Simone Castiello, Roberta Paolillo, Giuseppe Giugliano, Daniele Giacoppo, Alessandro Sciahbasi et al. · 2024 · Interventional Cardiology Clinics
35. Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration
    Amin Polzin, Marcel Benkhoff, Manuela Thienel, Maike Barcik, Philipp Mourikis, Khrystyna Shchurovska, Carolin Helten, Vincent Ehreiser, Zhe Zhang, Franziska von Wulffen et al. · 2024 · Journal of Thrombosis and Haemostasis
36. Direct Oral Anticoagulants: Quick Primer on When to Use and When to Avoid
    Antoine Bejjani, Behnood Bikdeli · 2024 · Thrombosis and Haemostasis
37. From WOEST to AUGUSTUS: a review of safety and efficacy of triple versus dual antithrombotic regimens in patients with atrial fibrillation requiring percutaneous coronary intervention for acute coronary syndrome
    David W. Jones, Sheharyar Minhas, Joseph J. Fierro, Devarshi R. Ardeshna, Aranyak Rawal, Brandon E. Cave, Samarth P. Shah, Rami N. Khouzam · 2019 · Annals of Translational Medicine
38. Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
    Andrea Rubboli, Marco Valgimigli, Davide Capodanno, Gregory Y.H. Lip · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
39. Cardiovascular Disease
    Susan P. Bell, Michael W. Rich · 2021 · Springer eBooks
40. Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art
    Abdullah K. Al-Abcha, Yasser Radwan, Danielle M. Blais, Ernest L. Mazzaferri, Konstantinos Dean Boudoulas, Essa M. Essa, Richard J. Gumina · 2022 · Frontiers in Cardiovascular Medicine
41. Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence
    Enrico Melillo, Andreina Carbone, Anna Rago, Andrea Antonio Papa, Antonio D’ Onofrio, Gerardo Nigro, Paolo Golino, Vincenzo Russo · 2019 · Journal of Cardiovascular Pharmacology
42. Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
    Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John Hunter Alexander, Marco Alings, Raffaele De Caterina, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Kurt Huber et al. · 2020 · JAMA Network Open
43. Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial
    Uwe Zeymer, Orly Leiva, Stefan Hans Hohnloser, Philippe Gabríel Steg, Jonas Oldgren, Georg Nickenig, Róbert Gábor Kiss, Zeki Öngen, Jose Luis Navarro Estrada, Ton Oude Ophuis et al. · 2021 · EuroIntervention
44. A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial
    Bastiaan Zwart, Willem L. Bor, A. J. W. M. de Veer, Bakhtawar Khan Mahmoodi, Johannes C. Kelder, Gregory Y.H. Lip, Deepak L. Bhatt, Christopher Paul Cannon, Jurriën M. ten Berg · 2022 · EuroIntervention
45. Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry
    Hiroyoshi Mori, Kazuki Fukui, Atsuo Maeda, Yoshihiro John Akashi, Junya Ako, Yuji Ikari, Toshiaki Ebina, Kouichi Tamura, Atsuo Namiki, Ichiro Michishita et al. · 2022 · Journal of Cardiology
46. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention
    Christoph B. Olivier, Jun Fan, Mariam Askari, Kenneth W. Mahaffey, Paul A. Heidenreich, Alexander C. Perino, George C. Leef, P. Michael Ho, Robert A. Harrington, Mintu P. Turakhia · 2019 · Circulation Cardiovascular Interventions
47. Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis
    Salvatore De Rosa, Jolanda Sabatino, Alberto Polimeni, Sabato Sorrentino, Ciro Indolfi · 2020 · PLoS ONE
48. Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short?
    Philipp Mourikis, Amin Polzin · 2023 · Journal of the American Heart Association
49. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention
    Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Masahiro Natsuaki, Yasuaki Takeji, Hirotoshi Watanabe, Yusuke Yoshikawa, Yukiko Matsumura‐Nakano, Satoshi Shizuta, Kengo Tanabe et al. · 2019 · The American Journal of Cardiology
50. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes
    Isabella Russo, Carola Griffith Brookles, Cristina Barale, Elena Melchionda, Amir Hassan Mousavi, Carloalberto Biolè, Alessandra Chinaglia, Matteo Bianco · 2024 · International Journal of Molecular Sciences
51. Ticagrelor or prasugrel vs. clopidogrel in combination with anticoagulation for treatment of acute coronary syndrome in patients with atrial fibrillation
    Irene Kirolos, Ikechukwu Ifedili, Miguel A. Maturana, Alykhan Premji, Brandon E. Cave, Sherif Roman, David Jones, Romany Gaid, Yehoshua C. Levine, Sunil Jha et al. · 2019 · Annals of Translational Medicine
52. Myocardial Infarction in the Group of Patients With Atrial Fibrillation
    Болдуева Светлана Афанасьевна, М. В. Соловьева, D. V. Oblavatckii, Valeria S. Feoktistova · 2020 · Kardiologiia
53. Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry
    Leonardo De Luca, Leonardo Bolognese, Andrea Rubboli, Alfredo Vetrano, Mariella Callerame, Luigi Rivetti, Lucio Gonzini, Domenico Gabrielli, Andrea Di Lenarda, Michele Massimo Gulizia et al. · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
54. Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges—A 70-Year Journey
    Dion A. Stub, Himawan Fernando, James D. McFadyen, Jathushan Palasubramaniam, James A. Shaw, Xiaowei Wang, Karlheinz Peter · 2020 · Thrombosis and Haemostasis
55. Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
    Renad Altoukhi, Reema A. Alshouimi, Shahad M. Al Rammah, Mohammed Alzahrani, Abdulaali R. Almutairi, Abdulmajeed M. Alshehri, Osamah M. Alfayez, Majed S. Al Yami, Omar A. Almohammed · 2020 · BMJ Open
56. Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas
    Shubhabrata Das, Anasua Deb, Tanmoy Pal · 2021 · Medical Principles and Practice
57. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19
    Malek Zarei, Navideh Sahebi Vaighan, Seyed Ali Ziai · 2021 · Immunopharmacology and Immunotoxicology
58. Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial
    Min Soo Cho, Do‐Yoon Kang, Yong‐Seog Oh, Chang Hoon Lee, Eue‐Keun Choi, Ji Hyun Lee, Chang Hee Kwon, Gyung‐Min Park, Hyun Woo Park, Kyoung‐Ha Park et al. · 2022 · American Heart Journal
59. Choice of antithrombotic therapy for patients with atrial fibrillation undergoing carotid angioplasty and stenting: a nationwide population-based study
    Yung-Chuan Huang, Yen-Chun Huang, Yu‐Chen Cheng, Mingchih Chen · 2022 · Scientific Reports
60. Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation
    Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Martin Bødtker Mortensen, Christine Gyldenkerne, Troels Thim, Bjarne Linde Nørgaard, Jesper Møller Jensen, Steen Dalby Kristensen et al. · 2022 · European Heart Journal - Cardiovascular Pharmacotherapy
61. Aging and Antithrombotic Treatment
    Emanuele Valeriani, Simona Bartimoccia, Pasquale Pignatelli, Daniele Pastori · 2023 · Antioxidants and Redox Signaling
62. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
    Marco Valgimigli, Alessandro Spirito, Samantha Sartori, Dominick Joseph Angiolillo, Pascal Vranckx, José M. de la Torre Hernández, Mitchell W. Krucoff, Sripal Bangalore, Deepak L. Bhatt, Gianluca Calogero Campo et al. · 2023 · JACC: Cardiovascular Interventions
63. Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarction
    Sissel Johanne Godtfredsen, Kristian Hay Kragholm, Anna Meta Dyrvig Kristensen, Tarek Bekfani, Rikke Sørensen, Maurizio Sessa, Christian Tobias Torp-Pedersen, Deepak L. Bhatt, Manan Pareek · 2023 · European Heart Journal Open
64. Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry
    Alessandro Sciahbasi, Salvatore De Rosa, Giuseppe Gargiulo, Daniele Giacoppo, Paolo Calabrò, Giovanni Paolo Talarico, Filippo Zilio, Giuseppe Talanas, Matteo Tebaldi, Giuseppe Andò et al. · 2024 · Journal of Cardiovascular Pharmacology
65. Management of Atrial Fibrillation
    Francis J. Alenghat, Jason T. Alexander, Gaurav A. Upadhyay · 2024 · JAMA
66. Direct-Acting Oral Anticoagulants in Atrial Fibrillation
    Filipe Ferrari, Anderson Donelli da Silveira, Vítor Magnus Martins, Leandro Tolfo Franzoni, Leandro Ioschpe Zimerman, Ricardo Stein · 2020 · Cardiology in Review
67. Novel Oral Anticoagulants Following Percutaneous Coronary Intervention
    Bryan Q. Abadie, Christopher Paul Cannon, Matthew Aaron Cavender · 2020 · Circulation Cardiovascular Interventions
68. Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel
    Nicola Mumoli, Claudia Amellone, Gianfranco Antonelli, Giuseppe Augello, Cosima Cloro, Alberto D’Alleva, Leonardo Di Ascenzo, Egidio Imbalzano, Renato Masala, Graziano Riccioni et al. · 2020 · CJC Open
69. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study
    Masato Nakamura, Takeshi Yamashita, Akiko Hayakawa, Takuyuki Matsumoto, Atsushi Takita, Chie Hasegawa, Kazuhiro Uchino, Toru Sekine, Tomoko Iizuka, Hirokazu Tanabe et al. · 2020 · Journal of Cardiology
70. Pharmacology before, during and after percutaneous coronary intervention
    Azfar Zaman, Qaiser Aleem · 2020 · Heart
71. Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
    Benjamin E. Peterson, Deepak L. Bhatt, Philippe Gabríel Steg, Jonas Oldgren, Michael Mæng, Uwe Zeymer, Sigrun Halvorsen, Stefan Hans Hohnloser, Gregory Y.H. Lip, Takeshi Kimura et al. · 2021 · JACC: Cardiovascular Interventions
72. Anticoagulation for Atrial Fibrillation: A Review of Current Literature and Views
    Chengyue Jin, Can Cui, Matthew Seplowe, Kyuin Lee, Rathnamitreyee Vegunta, Bo Li, William H. Frishman, Sei Iwai · 2022 · Cardiology in Review
73. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen
    Shoji Kawakami, Satoshi Yasuda, Hisao Ogawa · 2020 · Journal of Cardiology
74. How to Manage the Perioperative Patient on Combined Anticoagulant and Antiplatelet Therapy: Comments on the 2020 ACC Consensus Decision Pathway
    Daniel Bolliger, Jens Faßl, Gabor Erdoes · 2021 · Journal of Cardiothoracic and Vascular Anesthesia
75. Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry
    José M. de la Torre Hernández, José Luis Ferreiro, Ramón López‐Palop, Soledad Ojeda, David Martí Sánchez, Pablo Avanzas y, José Antonio Linares Vicente, Alejandro Diego‐Nieto, Ignacio Jesus Amat-Santos, Miren Tellería et al. · 2021 · International Journal of Cardiology
76. Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
    Marco Cattaneo, Lina Badimón, Giancarlo Agnelli, Andrew Tan Chan, Ángel Lanas, Bianca Rocca, Peter Malcolm Rothwell, Paola Patrignani, Ruth Elizabeth Langley, Gemma Vilahur et al. · 2020 · ecancermedicalscience
77. Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
    Alessio Menditto, Roberto Antonicelli · 2020 · Europe PMC (PubMed Central)
78. Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation
    Ugo Limbruno, Andreas Goette, Raffaele De Caterina · 2020 · International Journal of Cardiology
79. Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial
    Yohei Sotomi, Ken Kozuma, Kosuke Kashiwabara, Yoshiharu Higuchi, Kenji Andò, Yoshihiro Morino, Junya Ako, Kengo Tanabe, Takashi Muramatsu, Gaku Nakazawa et al. · 2021 · BMJ Open
80. Sex differences in patients with atrial fibrillation and acute coronary syndrome or undergoing PCI: a real-world study
    Yuyuan Shu, Si‐qi Lyu, Jiang‐Shan Tan, Han Zhang, Yimeng Wang, Lulu Wang, Yijing Xin, Yanmin Yang · 2024 · Acta cardiologica. Supplementum
81. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Yuichi Saito, Yoshio Kobayashi · 2019 · Cardiovascular Intervention and Therapeutics
82. Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
    Shujuan Zhao, Xuejiao Hong, Jingjing Cao, Haixia Cai, Song Du, Peizhi Ma · 2020 · Frontiers in Pharmacology
83. Kommentar zu den 2020er Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management des akuten Koronarsyndroms bei Patienten ohne persistierende ST-Strecken-Hebung
    Hölger Thiele, Johann K Bauersachs, Julinda Mehilli, Helge Möllmann, Ulf Landmesser, Alexander Jobs · 2021 · Der Kardiologe
84. Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention
    Xinbing Liu, Linlin Wang, Mingcheng Zhou, Liuliu Feng · 2021 · Contemporary Clinical Trials
85. Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)
    HOLGER M. NEF, Stephan S. Achenbach, Ralf Birkemeyer, Alexander Bufe, Oliver Dörr, Albrecht Elsässer, Luise Gaede, Tommaso Gori, Hans Martin Hoffmeister, Felix Johannes Hofmann et al. · 2021 · Der Kardiologe
86. A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes
    Mohammad Alkhalil, Michał Kuzemczak, Alan Bell, Sol Stern, Michelle Welsford, Warren J. Cantor, Shaun G. Goodman · 2022 · Canadian Medical Association Journal
87. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study
    Yan Xu, Tara Gomes, Philip Stephen Wells, Priscila Pequeno, Ana P Johnson, Michelle Sholzberg · 2022 · Thrombosis Research
88. Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent
    Alessandro Sciahbasi, Giuseppe Gargiulo, Giovanni Paolo Talarico, Arturo Cesaro, Filippo Zilio, Salvatore De Rosa, Giuseppe Talanas, Matteo Tebaldi, Giuseppe Andò, Stefano Rigattieri et al. · 2022 · Journal of Cardiovascular Medicine
89. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology
    Miguel Nobre Menezes, Marta Tavares da Silva, Andreia Magalhães, Bruno Melica, Júlia Toste, Rita Calé, Manuel Almeida, Manuela Fiúza, Eduardo Infante de Oliveira · 2023 · Revista Portuguesa de Cardiologia
90. In-hospital outcomes and postdischarge mortality in patients with acute coronary syndrome and atrial fibrillation
    Moussa Abbas Saleh, Kristie M. Coleman, Joanna Stein Fishbein, Amir Gandomi, Bo Kyung Yang, Andrew Kossack, Dimitrios Varrias, Rajiv Jauhar, Zoran Lasić, Michael Kim et al. · 2024 · Heart Rhythm
91. The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
    Evan S. Shlofmitz, Richard Shlofmitz, Michael S. Lee · 2019 · Korean Circulation Journal
92. Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trials
    Vincent Roule, Pierre Ardouin, Clément Briet, Adrien Lemaître, Mathieu Bignon, Rémi Sabatier, Laure Champ‐Rigot, Paul Milliez, Katrien Blanchart, Farzin Beygui · 2019 · Clinical Cardiology
93. Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy
    Fabiana Lucà, Giorgio Caretta, Fabio Vagnarelli, Marco Marini, Annamaria Iorio, Stefania Angela Di Fusco, Andrea Pozzi, Domenico Gabrielli, Furio Colivicchi, Leonardo De Luca et al. · 2020 · Journal of Cardiovascular Medicine
94. Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan
    Susumu Miyamoto, Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Yuji Murakawa, Sanghun Iwashiro, Makiko Takeichi, Yoko Kidani et al. · 2020 · Journal of Stroke and Cerebrovascular Diseases
95. Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta‐analysis
    Andrea Saglietto, Fabrizio D’Ascenzo, Daniele Errigo, Sergio Leonardi, Willem J.M. Dewilde, Federico Conrotto, Pierluigi Omedè, Antonio Montefusco, Filippo Angelini, Ovidio DE FILIPPO et al. · 2020 · Catheterization and Cardiovascular Interventions
96. Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?
    Massimo Volpe, Giovanna Gallo · 2020 · European Heart Journal Supplements
97. Triple Antithrombotic Therapy (Triple Therapy) After Percutaneous Coronary Intervention in Chronic Anticoagulation: A Literature Review
    Ali H Hussain, Amjad Minhas, Usman Sarwar, Hassan Tahir · 2022 · Cureus
98. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Jiesuck Park, Jin‐Hyung Jung, Eue‐Keun Choi, Seung‐Woo Lee, Soonil Kwon, So‐Ryoung Lee, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh et al. · 2022 · PLoS ONE
99. Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin
    Amit N. Vora, John Hunter Alexander, DANIEL M. WOJDYLA, RONALD S. ARONSON, Christopher Bull Granger, Harald Darius, Stephan Windecker, Roxana Mehran, Аверков Олег Валерьевич, Andrzej Budaj et al. · 2019 · Circulation
100. Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
     Ugo Limbruno, Francesco De Sensi, Alberto Cresti, Andréa Picchi, Fabio Lena, Raffaele De Caterina · 2020 · Journal of Clinical Medicine